As of 2024-07-27, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (40.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.92 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -1142.5%.
The range of the Relative Valuation is (30.69) - (44.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 6.2x - 14.7x | 10.2x |
Forward P/E multiples | 10.1x - 20.5x | 16.7x |
Fair Price | (30.69) - (44.72) | (40.87) |
Upside | -882.8% - -1240.9% | -1142.5% |
Date | P/E |
2024-07-26 | -1.29 |
2024-07-25 | -1.24 |
2024-07-24 | -1.29 |
2024-07-23 | -1.43 |
2024-07-22 | -1.32 |
2024-07-19 | -1.20 |
2024-07-18 | -1.20 |
2024-07-17 | -1.30 |
2024-07-16 | -1.40 |
2024-07-15 | -1.25 |
2024-07-12 | -1.18 |
2024-07-11 | -1.08 |
2024-07-10 | -0.96 |
2024-07-09 | -0.95 |
2024-07-08 | -0.92 |
2024-07-05 | -0.88 |
2024-07-03 | -0.88 |
2024-07-02 | -0.80 |
2024-07-01 | -0.85 |
2024-06-28 | -0.85 |
2024-06-27 | -0.85 |
2024-06-26 | -0.77 |
2024-06-25 | -0.77 |
2024-06-24 | -0.85 |
2024-06-21 | -0.88 |
2024-06-20 | -0.94 |
2024-06-18 | -0.92 |
2024-06-17 | -0.92 |
2024-06-14 | -0.93 |
2024-06-13 | -0.98 |
2024-06-12 | -1.00 |
2024-06-11 | -0.97 |
2024-06-10 | -0.90 |
2024-06-07 | -0.89 |
2024-06-06 | -0.95 |
2024-06-05 | -1.00 |
2024-06-04 | -0.96 |
2024-06-03 | -0.99 |
2024-05-31 | -0.93 |
2024-05-30 | -0.95 |
2024-05-29 | -0.92 |
2024-05-28 | -0.88 |
2024-05-24 | -0.89 |
2024-05-23 | -0.88 |
2024-05-22 | -0.96 |
2024-05-21 | -0.99 |
2024-05-20 | -1.04 |
2024-05-17 | -0.99 |
2024-05-16 | -1.04 |
2024-05-15 | -1.09 |